For in vitro diagnostic use. Others FCAL IVD FCAL CPS_000141 fCAL turbo 08 910 332 190 8 910 332 190 08910332190 8910332190 08910332190 fCAL, 200T, cobas c 501/502, PCh FCAL 07613336169926 Reagents, kits 200 tests cobas c 501/502 true 08 910 367 190 8 910 367 190 08910367190 8910367190 08910367190 fCAL, 200T, cobas c pack green, PCh FCAL 04260714340007 Reagents, kits 200 tests cobas c 303/503/703 true 0008910332190c501 FCAL fCAL turbo en 1 FF00000003CED60E FF00000003CED50E 08910332190 309 cobas c 501 2324 cobas c 502 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use The fCAL turbo is an in vitro diagnostic assay intended for the quantitative measurement of fecal calprotectin, a neutrophilic protein that is a marker of intestinal mucosal inflammation, in human stool. fCAL turbo aids in the diagnosis of inflammatory bowel disease (IBD), specifically Crohn's disease (CD) and ulcerative colitis (UC) and aids in the differentiation of IBD from irritable bowel syndrome (IBS) in conjunction with other laboratory and clinical findings. The fCAL turbo is intended to be run on cobas c 501/502 systems. en 0108910332190c501 FCAL fCAL turbo en 3 FF000000058C890E FF000000040D4A0E 08910332190 309 cobas c 501 2324 cobas c 502 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use The fCAL turbo is an automated in vitro diagnostic test for the quantitative determination of calprotectin in human stool specimens intended as an aid in the assessment of intestinal mucosal inflammation. The assay results can be used as an aid to diagnosis in distinguishing organic, inflammatory disease of the gastrointestinal tract (inflammatory bowel disease, IBD, specifically Crohn’s disease (CD) or ulcerative colitis (UC)) from functional disease (irritable bowel syndrome, IBS), in patients with chronic abdominal pain and as an aid to IBD disease monitoring. For laboratory use only. en 08910332500 FCAL fCAL turbo en 4 FF000000079C6B0E FF000000040D490E 08910332190 309 cobas c 501 2324 cobas c 502 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use The fCAL turbo is an automated in vitro diagnostic test for the quantitative determination of calprotectin in human stool specimens intended as an aid in the assessment of intestinal mucosal inflammation. The assay results can be used as an aid to diagnosis in distinguishing organic, inflammatory disease of the gastrointestinal tract (inflammatory bowel disease, IBD, specifically Crohn’s disease (CD) or ulcerative colitis (UC)) from functional disease (irritable bowel syndrome, IBS), in patients with chronic abdominal pain and as an aid to IBD disease monitoring. For laboratory use only.Disclaimer for South Korea: IBD monitoring claim does not apply. For Korean instruction for use please contact your local distributor. en 08910367500 FCAL fCAL turbo en 3 FF0000000797CE0E FF00000005A8840E 08910367190 9493 cobas c 303 8481 cobas c 503 10299 cobas c 703 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended use The fCAL turbo is an automated in vitro diagnostic test for the quantitative determination of calprotectin in human stool specimens intended as an aid in the assessment of intestinal mucosal inflammation. The assay results can be used as an aid to diagnosis in distinguishing organic, inflammatory disease of the gastrointestinal tract (inflammatory bowel disease, IBD, specifically Crohn’s disease (CD) or ulcerative colitis (UC)) from functional disease (irritable bowel syndrome, IBS), in patients with chronic abdominal pain and as an aid to IBD disease monitoring. For laboratory use only.Disclaimer for South Korea: IBD monitoring claim does not apply. For Korean instruction for use please contact your local distributor. en

User profile

Select your user profile

FCAL

Overview

Ordering information

Technical documents

Compatible products

Contact us